1. Refractory Thrombotic Thrombocytopenic Purpura in a Patient With Triple X Syndrome.
- Author
-
da Rocha Ribas PA, Ghiraldi J, Gugelmin G, Gortz LW, de Carvalho M, and Lenci Marques G
- Abstract
Clinical manifestations of triple X syndrome (karyotype 47, XXX) can include autoimmune diseases. We describe the occurrence of acquired thrombotic thrombocytopenic purpura (TTP), an autoimmune condition, refractory to plasmapheresis and rituximab in a patient with triple X syndrome who required vincristine administration for disease remission. To our knowledge, this rare coexistence is the first of its kind reported in Brazil., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Clinical Hospital Complex of the Federal University of Paraná, Curitiba, Paraná, Brazil. issued approval 6.920.024. In view of the above, the Human Research Ethics Committee of the HC-UFPR, in accordance with the attributions defined in CNS Resolution 466/2012 and in CNS Operational Standard No. 001/2013, expresses its approval of the Case Report , as proposed. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, da Rocha Ribas et al.)
- Published
- 2024
- Full Text
- View/download PDF